CLINICAL TRIALS & RESEARCH
Resources

Response to the proposed revision of the EU general pharmaceuticals legislation

Public Comments

Comments submitted on: July 30, 2023

Comments submitted to: European Commission

Details: The MRCT Center submitted public comments on the proposed revision of the EU general pharmaceuticals legislation. In broad support of merging the Paediatrics Regulation with general pharmaceuticals legislation, our comments urged the European Commission to ensure pediatric medicines development remains an implementation priority to meet the needs of children throughout Europe.